{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:44:06Z","timestamp":1762508646215,"version":"3.37.3"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"3-4","funder":[{"name":"VIR Biotechnology Inc","award":["2101000367"],"award-info":[{"award-number":["2101000367"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,3,20]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>Early identification of patients with coronavirus disease 2019 (COVID-19) who are at risk for hospitalization may help to mitigate disease burden by allowing healthcare systems to conduct sufficient resource and logistical planning in the event of case surges. We sought to develop and validate a clinical risk score that uses readily accessible information at testing to predict individualized 30-day hospitalization risk following COVID-19 diagnosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We assembled a retrospective cohort of U.S. Veterans Health Administration patients (age\u2009\u2265\u200918\u2009years) diagnosed with COVID-19 between March 1, 2020, and December 31, 2020. We screened patient characteristics using Least Absolute Shrinkage and Selection Operator logistic regression and constructed the risk score using characteristics identified as most predictive for hospitalization. Patients diagnosed before November 1, 2020, comprised the development cohort, while those diagnosed on or after November 1, 2020, comprised the validation cohort. We assessed risk score discrimination by calculating the area under the receiver operating characteristic (AUROC) curve and calibration using the Hosmer\u2013Lemeshow (HL) goodness-of-fit test. This study was approved by the Veteran\u2019s Institutional Review Board of Northern New England at the White River Junction Veterans Affairs Medical Center (Reference no.:1473972-1).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The development and validation cohorts comprised 11,473 and 12,970 patients, of whom 4,465 (38.9%) and 3,669 (28.3%) were hospitalized, respectively. The independent predictors for hospitalization included in the risk score were increasing age, male sex, non-white race, Hispanic ethnicity, homelessness, nursing home\/long-term care residence, unemployed or retired status, fever, fatigue, diarrhea, nausea, cough, diabetes, chronic kidney disease, hypertension, and chronic obstructive pulmonary disease. Model discrimination and calibration was good for the development (AUROC\u2009=\u20090.80; HL P-value\u2009=\u2009.05) and validation (AUROC\u2009=\u20090.80; HL P-value\u2009=\u2009.31) cohorts.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The prediction tool developed in this study demonstrated that it could identify patients with COVID-19 who are at risk for hospitalization. This could potentially inform clinicians and policymakers of patients who may benefit most from early treatment interventions and help healthcare systems anticipate capacity surges.<\/jats:p><\/jats:sec>","DOI":"10.1093\/milmed\/usab415","type":"journal-article","created":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T11:20:59Z","timestamp":1633778459000},"page":"e833-e840","source":"Crossref","is-referenced-by-count":2,"title":["Development and Validation of a Clinical Risk Score to Predict Hospitalization Within 30 Days of Coronavirus Disease 2019 Diagnosis"],"prefix":"10.1093","volume":"188","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6140-4250","authenticated-orcid":false,"given":"Maya","family":"Aboumrad","sequence":"first","affiliation":[{"name":"Clinical Epidemiology Program, White River Junction Veterans Affairs Medical Center , White River Junction, VT 05009, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabrielle","family":"Zwain","sequence":"additional","affiliation":[{"name":"Clinical Epidemiology Program, White River Junction Veterans Affairs Medical Center , White River Junction, VT 05009, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy","family":"Smith","sequence":"additional","affiliation":[{"name":"Clinical Epidemiology Program, White River Junction Veterans Affairs Medical Center , White River Junction, VT 05009, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nabin","family":"Neupane","sequence":"additional","affiliation":[{"name":"Clinical Epidemiology Program, White River Junction Veterans Affairs Medical Center , White River Junction, VT 05009, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ethan","family":"Powell","sequence":"additional","affiliation":[{"name":"Clinical Epidemiology Program, White River Junction Veterans Affairs Medical Center , White River Junction, VT 05009, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brendan","family":"Dempsey","sequence":"additional","affiliation":[{"name":"Clinical Epidemiology Program, White River Junction Veterans Affairs Medical Center , White River Junction, VT 05009, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina","family":"Reyes","sequence":"additional","affiliation":[{"name":"Division of Health Economics and Outcomes Research, VIR Biotechnology Inc. , San Francisco, CA 94158, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sacha","family":"Satram","sequence":"additional","affiliation":[{"name":"Division of Health Economics and Outcomes Research, VIR Biotechnology Inc. , San Francisco, CA 94158, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinong","family":"Young-Xu","sequence":"additional","affiliation":[{"name":"Clinical Epidemiology Program, White River Junction Veterans Affairs Medical Center , White River Junction, VT 05009, USA"},{"name":"Department of Psychiatry, Geisel School of Medicine at Dartmouth , Hanover, NH 03755, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,10,6]]},"reference":[{"issue":"3","key":"2023033100474257600_","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105924","article-title":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and corona virus disease-2019 (COVID-19): the epidemic and the challenges","volume":"55","author":"Lai","year":"2020","journal-title":"Int J Antimicrob Agents"},{"author":"Centers for Disease Control and Prevention","key":"2023033100474257600_","article-title":"Coronavirus disease 2019 (COVID-19): cases, data, & surveillance"},{"author":"Centers for Disease Control and Prevention","key":"2023033100474257600_","article-title":"COVIDView: a weekly surveillance summary of US COVID-19 activity"},{"article-title":"COVID-19 response plan","year":"2020","author":"Veterans Health Administration Office of Emergency Management","key":"2023033100474257600_"},{"issue":"8","key":"2023033100474257600_","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/s41591-020-0952-y","article-title":"Disease and healthcare burden of COVID-19 in the United States","volume":"26","author":"Miller","year":"2020","journal-title":"Nat Med"},{"issue":"16","key":"2023033100474257600_","doi-asserted-by":"crossref","first-page":"9122","DOI":"10.1073\/pnas.2004064117","article-title":"Projecting hospital utilization during the COVID-19 outbreaks in the United States","volume":"117","author":"Moghadas","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"2023033100474257600_","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S1473-3099(20)30190-0","article-title":"Scientific and ethical basis for social-distancing interventions against COVID-19","volume":"20","author":"Lewnard","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"2023033100474257600_","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2021.14811","article-title":"Confronting the delta variant of SARS-CoV-2, Summer 2021","author":"Del Rio","year":"2021","journal-title":"JAMA"},{"key":"2023033100474257600_","article-title":"Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study","volume":"371","author":"Clift","year":"2020","journal-title":"BMJ"},{"issue":"8","key":"2023033100474257600_","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0237419","article-title":"Development and validation of a model for individualized prediction of hospitalization risk in 4,536 patients with COVID-19","volume":"15","author":"Jehi","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"2023033100474257600_","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/infdis\/jiaa663","article-title":"CoVA: an acuity score for outpatient screening that predicts coronavirus disease 2019 prognosis","volume":"223","author":"Sun","year":"2021","journal-title":"J Infect Dis"},{"key":"2023033100474257600_","article-title":"Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal","volume":"369","author":"Wynants","year":"2020","journal-title":"BMJ"},{"issue":"3","key":"2023033100474257600_","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJMoa2029849","article-title":"SARS-CoV-2 neutralizing antibody LY-CoV555 in outpatients with Covid-19","volume":"384","author":"Chen","year":"2021","journal-title":"N Engl J Med"},{"issue":"7","key":"2023033100474257600_","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1001\/jama.2021.0202","article-title":"Effect of bamlanivimab as monotherapy or in combination with etesevimab on viral load in patients with mild to moderate COVID-19: a randomized clinical trial","volume":"325","author":"Gottlieb","year":"2021","journal-title":"JAMA"},{"year":"2021","author":"Vir Biotechnology Inc.","key":"2023033100474257600_"},{"key":"2023033100474257600_","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa2035002","article-title":"REGN-COV2, a neutralizing antibody cocktail, in outpatients with Covid-19","author":"Weinreich","year":"2021","journal-title":"N Engl J Med"},{"issue":"11","key":"2023033100474257600_","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0241825","article-title":"Development and validation of a 30-day mortality index based on pre-existing medical administrative data from 13,323 COVID-19 patients: the Veterans Health Administration COVID-19 (VACO) Index","volume":"15","author":"King","year":"2020","journal-title":"PLoS One"},{"issue":"4","key":"2023033100474257600_","article-title":"Current and projected characteristics and unique health care needs of the patient population served by the Department of Veterans Affairs","volume":"5","author":"Eibner","year":"2016","journal-title":"Rand Health Q"},{"article-title":"Coronavirus (Covid-19) data in the United States","year":"2021","author":"The New York Times","key":"2023033100474257600_"},{"article-title":"Benefits of getting a COVID-19 vaccine","year":"2021","author":"Centers for Disease Control and Prevention","key":"2023033100474257600_"},{"issue":"5","key":"2023033100474257600_","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1093\/ije\/dyaa140","article-title":"Characteristics and predictors of hospitalization and death in the first 11 122 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: a nationwide cohort","volume":"49","author":"Reilev","year":"2020","journal-title":"Int J Epidemiol"},{"issue":"8","key":"2023033100474257600_","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1001\/jamainternmed.2020.2033","article-title":"Development and validation of a clinical risk score to predict the occurrence of critical illness in hospitalized patients with COVID-19","volume":"180","author":"Liang","year":"2020","journal-title":"JAMA Intern Med"},{"key":"2023033100474257600_","article-title":"Natural history of COVID-19: risk factors for hospitalizations and deaths among&gt; 26 million US Medicare beneficiaries","author":"Izurieta","year":"2021","journal-title":"J Infect Dis"},{"issue":"12","key":"2023033100474257600_","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.24345","article-title":"Evaluation of changes in Veterans Affairs Medical Centers\u2019 mortality rates after risk adjustment for socioeconomic status","volume":"3","author":"Trivedi","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"5","key":"2023033100474257600_","doi-asserted-by":"crossref","first-page":"469","DOI":"10.7205\/MILMED-D-15-00094","article-title":"Veterans Affairs health system enrollment and health care utilization after the Affordable Care Act: initial insights","volume":"181","author":"Silva","year":"2016","journal-title":"Mil Med"},{"issue":"6","key":"2023033100474257600_","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s10597-017-0215-7","article-title":"Socioeconomic disparities and metabolic risk in veterans with serious mental illness","volume":"54","author":"Caroff","year":"2018","journal-title":"Community Ment Health J"},{"article-title":"ICD-10-CM official coding and reporting guidelines April 1, 2020 through September 30, 2020","year":"2020","author":"Centers for Disease Control and Prevention","key":"2023033100474257600_"},{"article-title":"Defining adult overweight and obesity","year":"2021","author":"Centers for Disease Control and Prevention","key":"2023033100474257600_"},{"article-title":"US influenza vaccine effectiveness network protocol for influenza and other respiratory viruses (including COVID-19)","year":"2021","author":"Centers for Disease Control and Prevention","key":"2023033100474257600_"},{"issue":"5","key":"2023033100474257600_","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"issue":"3","key":"2023033100474257600_","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0895-4356(02)00585-1","article-title":"How to measure comorbidity: a critical review of available methods","volume":"56","author":"De Groot","year":"2003","journal-title":"J Clin Epidemiol"},{"key":"2023033100474257600_","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","author":"Quan","year":"2005","journal-title":"Med Care"},{"key":"2023033100474257600_","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajic.2021.02.012","article-title":"Impact of the influenza vaccine on COVID-19 infection rates and severity","author":"Conlon","year":"2021","journal-title":"Am J Infect Control"},{"issue":"7","key":"2023033100474257600_","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0246217","article-title":"Trends in COVID-19 cases and clinical management in Veterans Health Administration medical facilities: a national cohort study","volume":"16","author":"Aboumrad","year":"2021","journal-title":"PLoS One"},{"key":"2023033100474257600_","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s00038-020-01390-7","article-title":"Predictive symptoms and comorbidities for severe COVID-19 and intensive care unit admission: a systematic review and meta-analysis","volume":"65","author":"Jain","year":"2020","journal-title":"Int J Public Health"},{"issue":"5","key":"2023033100474257600_","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.amepre.2012.07.029","article-title":"Health and health behavior differences: US Military, veteran, and civilian men","volume":"43","author":"Hoerster","year":"2012","journal-title":"Am J Prev Med"},{"article-title":"Veteran homelessness: a supplemental report to the 2009 Annual Homeless Assessment Report to Congress","year":"2020","author":"Khadduri","key":"2023033100474257600_"},{"article-title":"VA Health Care: VA faces challenges in meeting demand for long-term care","year":"2020","author":"Clowers","key":"2023033100474257600_"},{"issue":"2","key":"2023033100474257600_","first-page":"52","article-title":"The Veterans Health Administration approach to COVID-19 vaccine allocation\u2014balancing utility and equity","volume":"38","author":"Tarzian","year":"2021","journal-title":"Fed Pract"},{"issue":"1","key":"2023033100474257600_","doi-asserted-by":"crossref","first-page":"61","DOI":"10.7326\/M20-1212","article-title":"Collision of the COVID-19 and addiction epidemics","volume":"173","author":"Volkow","year":"2020","journal-title":"Ann Intern Med"}],"container-title":["Military Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/milmed\/article-pdf\/188\/3-4\/e833\/49703619\/usab415.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/milmed\/article-pdf\/188\/3-4\/e833\/49703619\/usab415.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T17:07:15Z","timestamp":1699636035000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/milmed\/article\/188\/3-4\/e833\/6382065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,6]]},"references-count":40,"journal-issue":{"issue":"3-4","published-online":{"date-parts":[[2021,10,6]]},"published-print":{"date-parts":[[2023,3,20]]}},"URL":"https:\/\/doi.org\/10.1093\/milmed\/usab415","relation":{},"ISSN":["0026-4075","1930-613X"],"issn-type":[{"type":"print","value":"0026-4075"},{"type":"electronic","value":"1930-613X"}],"subject":[],"published-other":{"date-parts":[[2023,3,1]]},"published":{"date-parts":[[2021,10,6]]}}}